Education
About Us
Working with TipRanks
Follow Us
Suven Pharmaceuticals Ltd. (IN:SUVENPHAR)
:SUVENPHAR
See the Price Targets and Ratings of:
SUVENPHAR Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
₹1,135
Hold
18.45%
Upside
Reiterated
07/25/25
Goldman Sachs
₹1,350
Buy
40.88%
Upside
Initiated
04/08/25
Macquarie
₹1,500
Buy
56.54%
Upside
Reiterated
03/28/25
ICICI Securities
₹1,400
Buy
46.10%
Upside
Initiated
03/25/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
₹1,135
Hold
18.45%
Upside
Reiterated
07/25/25
Goldman Sachs
₹1,350
Buy
40.88%
Upside
Initiated
04/08/25
Macquarie
₹1,500
Buy
56.54%
Upside
Reiterated
03/28/25
ICICI Securities
₹1,400
Buy
46.10%
Upside
Initiated
03/25/25
Best Analysts Covering Suven Pharmaceuticals Ltd.
1 Month
xxx
Success Rate
1/2 ratings generated profit
Average Return
-0.50%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -0.50% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
Average Return
-13.05%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -13.05% per trade.
1 Year
Success Rate
0/2 ratings generated profit
Average Return
-19.30%
reiterated a buy rating 4 months ago
Copying Kunal Dhamesha's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -19.30% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
Average Return
-17.35%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -17.35% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SUVENPHAR Analyst Recommendation Trends
Rating
Feb 25
Mar 25
Apr 25
Jul 25
Strong Buy
0
0
0
0
Buy
1
3
4
3
Hold
0
0
0
7
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
3
4
10
Each month's total comprises the sum of three months' worth of ratings.
SUVENPHAR Stock Forecast FAQ
What is IN:SUVENPHAR’s average 12-month price target, according to analysts?
Based on analyst ratings, Suven Pharmaceuticals Ltd.’s 12-month average price target is 1,416.67.
What is IN:SUVENPHAR’s upside potential, based on the analysts’ average price target?
Suven Pharmaceuticals Ltd. has 47.84% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Suven Pharmaceuticals Ltd. a Buy, Sell or Hold?
Suven Pharmaceuticals Ltd. has a consensus rating of Strong Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Suven Pharmaceuticals Ltd.’s share price target?
The average share price target for Suven Pharmaceuticals Ltd. is 1,416.67. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,500.00 ,and the lowest forecast is ₹1,350.00. The average share price target represents 47.84% Increase from the current price of ₹958.25.
The highest analyst share price target is ₹1,500.00 ,and the lowest forecast is ₹1,350.00. The average share price target represents 47.84% Increase from the current price of ₹958.25.
What do analysts say about Suven Pharmaceuticals Ltd.?
Suven Pharmaceuticals Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Suven Pharmaceuticals Ltd.?
To buy shares of IN:SUVENPHAR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.